Guardant360 CDx is a liquid biopsy test that provides the answers your doctor needs to build your treatment plan.
As a blood test, Guardant360 CDx captures the DNA that is shed from your tumor. This provides a comprehensive overview of your cancer genomics from both your primary tumor and any metastatic sites. Guardant360 CDx examines 50+ clinically relevant genes to identify select genomic biomarkers specific to your cancer, while avoiding the complications and delays of a tissue biopsy.
Your doctor may order Guardant360 CDx for advanced cancer: